Systemic manifestations and symptom burden of facioscapulohumeral muscular dystrophy in a referral cohort.

FSHD demonstrates a broad clinical phenotype. Increased vigilance among neurologists to screen for systemic manifestations of the disease is warranted. More uniform screening and future population-based studies are needed to compare findings in FSHD patients with the general population.